About
bioDesign
A medical device company building a strategic, multi-product platform in the areas of detection, treatment, monitoring, and prevention.
Our Principles
01
User-Centered Design
We interview, observe existing and potential customers, then prototype and test our concepts to develop and insure safety, usability, and value..
02
Market Channel Compatibility
Our sales integrate with existing B to B channels—no disruption to your supply chain or regulatory status—as well as take advantage of new direct-to-customer channels.
03
Commercial Discipline
Our product development process includes plans for clear regulatory pathway, marketing strategy, and unit economics.
04
Production Expertise
We rely on our decades of experience with bringing products to market manufacturers with regulatory requirements, quality, and timely delivery.
bioDesign Group Technologies, Inc. is a medical device company focused on assistive and interventional devices — creating with principled human factors at the intersection of drug delivery and engineering - ranging from institutional patient-centric healthcare purchasing.
Our flagship products — STiK and SkinClip — are in the FDA 510(k) clearance process. Commercial launch targeted for Q1 2027.
Product Timeline
Product Launch Phase
STiK - Syringe Assist Device
FDA 510(k) 2026 · Q1 2027
Product Launch Phase
SkinClip - Wound Closure System
FDA 510(k) 2026. Q1 2027
Product Review/Approval Phase
ViTell - Human Temperature Monitor
Development stage
Product Review/Approval Phase
SampleTell - Home Disease Testing
Development stage · COVID, flu, and more
Product Review/Approval Phase
DenTell - Dental Implant System
Development stage